Abstract 11711: Quantification of Atherosclerotic Coronary Artery Disease in the Pre/Peri-Menopausal Female Using Cardiac CTA
Phoenix
Interventional cardiology
DOI:
10.1161/circ.144.suppl_1.11711
Publication Date:
2022-03-19T23:58:21Z
AUTHORS (7)
ABSTRACT
Introduction: Coronary Artery Disease (CAD) occurs equally in males and females is the most common cause of death both genders worldwide. The pre/peri-menopausal female believed to have minimal coronary atherosclerosis based primarily on non-invasive techniques, with limited angiography data. Cardiac computed tomography (CCTA) a more sensitive, anatomical diagnostic tool for quantifying atherosclerosis, but women been underrepresented underdiagnosed. goal this study was quantify population. Methods: We conducted retrospective chart review 510 aged 35-60 presenting atypical chest pain shortness breath. These were consecutive admissions which CCTA performed from January 2014 December 2019. degree quantified using CAD-RADS scoring system. Results: Analysis showed 68.82% patients had no evidence atherosclerosis. 4.31% CAD, 18.24% mild 6.47% moderate CAD 2.16% found severe CAD. Each category stenosis typically multiple vessels involved. Over 65% Non-Hispanic White, 27% Hispanic, 8% African American 4% Asian. Less than 5% discharged statin therapy. Conclusions: This first female. Quantification angiograms obtained by CCTA, currently sensitive imaging technique. Despite perceived protective nature premenopausal state women, 30% detectable CCTA. 10% greater 50% (moderate CAD), suggesting potential future ischemic heart disease. So few therapy, showing paucity guideline therapy used results suggest targeting preventative even late pre or peri-menopausal stage, such as favorable lifestyle changes reducing known modifiable cardiac risk factors, should significantly prevent progression its subsequent sequelae menopause.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....